Editorial: Exercise for NAFLD: Does intensity matter

American Journal of Gastroenterology

Volumn 106, Issue 3, 2011, Pages 470-475

  Conjeevaram, Hari S ^a   Tiniakos, Dina G ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; METFORMIN; PLACEBO;

AEROBIC EXERCISE; BEHAVIOR MODIFICATION; DIABETES MELLITUS; DISEASE SEVERITY; EXERCISE INTENSITY; FATTY ACID OXIDATION; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE MODIFICATION; LIVER BIOPSY; LIVER FIBROSIS; LIVER HISTOLOGY; LOW CALORY DIET; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUTRITIONAL COUNSELING; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; WEIGHT REDUCTION;

ANIMALS; CLINICAL TRIALS AS TOPIC; DIET, REDUCING; EXERCISE; FATTY LIVER; FOOD HABITS; HUMANS; LIFE STYLE; LIVER CIRRHOSIS; MOTOR ACTIVITY; SEVERITY OF ILLNESS INDEX; WEIGHT LOSS;

EID: 79952349069     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.496     Document Type: Review

References (25)

1. Ong JP, Younossi ZM. Epidemiology and natural history of NAFLD and NASH. Clin Liver Dis 2007;11:1-16. (Pubitemid 46829973)
2. Starley BQ, Calcagno CJ, Harrison SA. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology 2010;51:1820-32.
3. Adams LA, Angulo P. Recent concepts in non-alcoholic fatty liver disease. Diabet Med 2005;22:1129-33. (Pubitemid 41224168)
4. Johnson NA, George J. Fitness versus fatness: moving beyond weight loss in nonalcoholic fatty liver disease. Hepatology 2010;52:370-81.
5. Ratziu V, Zelber-Sagi S. Pharmacologic therapy of non-alcoholic steatohepatitis . Clin Liver Dis 2009;13:667-88.
6. Sanyal AJ, Chalasani N, Kowdley KV et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 2010;362:1675-85.
7. Knowler WC, Barrett-Connor E, Fowler SE et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403. (Pubitemid 34437694)
8. Carroll JF, Franks SF, Smith AB et al. Visceral adipose tissue loss and insulin resistance 6 months aft er laparoscopic gastric banding surgery: a preliminary study. Obes Surg 2009;19:47-55.
9. Rector RS, Thyfault JP, Morris RT et al. Daily exercise increases hepatic fatty acid oxidation and prevents steatosis in Otsuka Long-Evans Tokushima Fatty rats. Am J Physiol Gastrointest Liver Physiol 2008;294:G619-26. (Pubitemid 351468778)
10. Mikus CR, Rector RS, Arce-Esquivel AA et al. Daily physical activity enhances reactivity to insulin in skeletal muscle arterioles of hyperphagic Otsuka Long-Evans Tokushima Fatty rats. J Appl Physiol 2010;109:1203-10.
11. Laye MJ, Rector RS, Warner SO et al. Changes in visceral adipose tissue mitochondrial content with type 2 diabetes and daily voluntary wheel running in OLETF rats. J Physiol 2009;587:3729-39.
12. Vieira VJ, Valentine RJ, Wilund KR et al. Effects of diet and exercise on metabolic disturbances in high-fat diet-fed mice. Cytokine 2009;46:339-45.
13. Bradley RL, Jeon JY, Liu FF et al. Voluntary exercise improves insulin sensitivity and adipose tissue inflammation in diet-induced obese mice. Am J Physiol Endocrinol Metab 2008;295:E586-94.
14. Hannukainen JC, Borra R, Lindeborg K et al. Liver and pancreatic fat content and metabolism in healthy monozygotic twins discordant for physical activity. J Hepatol 2010;advance online publication, 19 September 2010; doi:10.1016/j.jhep.2010.07.029 (in press).
15. Kistler K, Brunt EM, Clark JM, et al., NASH Clinical Research Network. Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease. Am J Gastroenterol 2011;106:460-8 (this issue).
16. Ueno T, Sugawara H, Sujaku K et al. Therapeutic Effects of restricted diet and exercise in obese patients with fatty liver. J Hepatol 1997;27:103-7. (Pubitemid 27357062)
17. Huang MA, Greenson JK, Chao C et al. One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study. Am J Gastroenterol 2005;100:1072-81. (Pubitemid 40769044)
18. Nobili V, Manco M, Ciampalini P et al. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study. Clin Ther 2008;30:1168-76. (Pubitemid 351978124)
19. Nobili V, Manco M, Devito R et al. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatology 2008;48:119-28. (Pubitemid 351975537)
20. Vilar-Gomez E, Rodriguez DM, Gra OB et al. Clinical trial: a nutritional supplement Viusid, in combination with diet and exercise, in patients with nonalcoholic fatty liver disease. Aliment Pharmacol Ther 2009;30:999-1009.
21. Promrat K, Kleiner DE, Niemeier HM et al. Randomized controlled trial testing the Effects of weight loss on nonalcoholic steatohepatitis. Hepatology 2010;51:121-9.
22. Kleiner DE, Brunt EM, Van Natta M et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313-21. (Pubitemid 40770284)
23. Krasnoff JB, Painter PL, Wallace JP et al. Health-related fitness and physical activity in patients with nonalcoholic fatty liver disease. Hepatology 2008;47:1158-66.
24. Frith J, Day CP, Robinson L et al. Potential strategies to improve uptake of exercise interventions in non-alcoholic fatty liver disease. J Hepatol 2010;52:112-6.
25. Bellentani S, Dalle GR, Suppini A et al. Behavior therapy for nonalcoholic fatty liver disease: the need for a multidisciplinary approach. Hepatology 2008;47:746-54. (Pubitemid 351280743)